ABVC BioPharma
Stock Forecast, Prediction & Price Target

ABVC BioPharma Financial Estimates

ABVC BioPharma Revenue Estimates

ABVC BioPharma EBITDA Estimates

ABVC BioPharma Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026
Revenue
 
% change YoY
$355.79K
 
N/A
$969.78K
 
172.56%
$152.43K
 
-84.28%
Avg: $4.17M
Low: $4.17M
High: $4.17M
avg. 2637.65%
Avg: $35.28M
Low: $35.28M
High: $35.28M
avg. 745.53%
Net Income
 
% change YoY
$-12.03M
 
N/A
$-16.31M
 
-35.53%
$-10.51M
 
35.53%
Avg: $-19.94M
Low: $-19.94M
High: $-19.94M
avg. -89.66%
Avg: $5.63M
Low: $5.63M
High: $5.63M
avg. 128.26%
EBITDA
 
% change YoY
$-11.12M
 
N/A
$-14.81M
 
-33.17%
$-8.13M
 
45.12%
Avg: $-4.17M
Low: $-4.17M
High: $-4.17M
avg. 48.68%
Avg: $-35.28M
Low: $-35.28M
High: $-35.28M
avg. -745.53%
EPS
 
% change YoY
-$4.8
 
N/A
-$5.15
 
-7.29%
-$2.43
 
52.81%
Avg: -$4.6
Low: -$4.6
High: -$4.6
avg. -89.30%
Avg: $1.3
Low: $1.3
High: $1.3
avg. 128.26%
Operating Expenses
 
% change YoY
$11.69M
 
N/A
$15.79M
 
35.07%
$8.06M
 
-48.93%
Avg: $93.62M
Low: $93.62M
High: $93.62M
avg. 1060.58%
Avg: $791.61M
Low: $791.61M
High: $791.61M
avg. 745.53%

FAQ

What is ABVC BioPharma stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 19.30% in 2025-2026.

We have gathered data from N/A analysts. Their low estimate is -19.94M, average is -19.94M and high is -19.94M.

What is ABVC BioPharma stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 1691.59% in 2025-2026.

We have gathered data from N/A analysts. Their low revenue estimate is $4.17M, average is $4.17M and high is $4.17M.

What is ABVC BioPharma stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 19.48% in 2025-2026.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$4.6, average is -$4.6 and high is $-4.6.